Dosimetry-Based Consideration on Remission and Relapse after Therapy with ²²³Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report

By Mangano Anna Maria   Pacilio Massimiliano   Ialongo Pasquale   Semprebene Alessandro   Ventroni Guido   Mango Lucio  

Diagnostics, Vol. 8, Iss. 1, 2018-02 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer

By Binder Moritz   Zhang Ben Y.   Hillman David W.   Kohli Rhea   Kohli Tanvi   Lee Adam   Kohli Manish  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1097-1097

MDPI

Access to resources Recommend Favorite

Angiosarcoma of the Scalp: Metastatic Pulmonary Cystic Lesions Initially Misinterpreted as Benign Findings on 18F-FDG PET/CT

By Andersen Kim Francis   Albrecht-Beste Elisabeth   Berthelsen Anne Kiil   Loft Annika  

Diagnostics, Vol. 6, Iss. 1, 2015-12 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite

An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography ¹⁸F-FLT PET/CT in Prostate Adenocarcinoma

By Kairemo Kalevi   Ravizzini Gregory C.   Macapinlac Homer A.   Subbiah Vivek  

Diagnostics, Vol. 7, Iss. 2, 2017-04 ,pp. : 20-20

MDPI

Access to resources Recommend Favorite

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer

By Schlack Katrin   Krabbe Laura-Maria   Fobker Manfred   Schrader Andres Jan   Semjonow Axel   Boegemann Martin  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1520-1520

MDPI

Access to resources Recommend Favorite